Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sage Therapeutics, Inc. | Senior Vice President, General Counsel and Secretary | Common Stock | 20K | $179K | $8.96 | Nov 1, 2024 | Direct |
Sage Therapeutics, Inc. | Senior Vice President, General Counsel and Secretary | Stock Option (Right to buy) | 10K | Nov 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SAGE | Sage Therapeutics, Inc. | Nov 1, 2024 | 2 | $0 | 4 | Nov 1, 2024 | Senior Vice President, General Counsel and Secretary |
SAGE | Sage Therapeutics, Inc. | Nov 1, 2024 | 0 | $0 | 3 | Nov 1, 2024 | Senior Vice President, General Counsel and Secretary Exhibit Index: 24.1 Power of Attorney |